Hyperglucagonemia Does Not Explain the β-Cell Hyperresponsiveness and Insulin Resistance in Dysglycemic Youth Compared With Adults: Lessons From the RISE Study

dc.contributor.authorKahn, Steven E.
dc.contributor.authorMather, Kieren J.
dc.contributor.authorArslanian, Silva A.
dc.contributor.authorBarengolts, Elena
dc.contributor.authorBuchanan, Thomas A.
dc.contributor.authorCaprio, Sonia
dc.contributor.authorEhrmann, David A.
dc.contributor.authorHannon, Tamara S.
dc.contributor.authorMarcovina, Santica
dc.contributor.authorNadeau, Kristen J.
dc.contributor.authorUtzschneider, Kristina M.
dc.contributor.authorXiang, Anny H.
dc.contributor.authorEdelstein, Sharon L.
dc.contributor.authorThe RISE Consortium
dc.contributor.departmentMedicine, School of Medicine
dc.date.accessioned2023-09-01T10:55:13Z
dc.date.available2023-09-01T10:55:13Z
dc.date.issued2021
dc.description.abstractObjective: To determine whether β-cell hyperresponsiveness and insulin resistance in youth versus adults in the Restoring Insulin Secretion (RISE) Study are related to increased glucagon release. Research design and methods: In 66 youth and 350 adults with impaired glucose tolerance (IGT) or recently diagnosed type 2 diabetes (drug naive), we performed hyperglycemic clamps and oral glucose tolerance tests (OGTTs). From clamps we quantified insulin sensitivity (M/I), plasma fasting glucagon and C-peptide, steady-state glucagon and C-peptide at glucose of 11.1 mmol/L, and arginine-stimulated glucagon (acute glucagon response [AGR]) and C-peptide (ACPRmax) responses at glucose >25 mmol/L. Results: Mean ± SD fasting glucagon (7.63 ± 3.47 vs. 8.55 ± 4.47 pmol/L; P = 0.063) and steady-state glucagon (2.24 ± 1.46 vs. 2.49 ± 1.96 pmol/L, P = 0.234) were not different in youth and adults, respectively, while AGR was lower in youth (14.1 ± 5.2 vs. 16.8 ± 8.8 pmol/L, P = 0.001). Significant age-group differences in insulin sensitivity, fasting C-peptide, steady-state C-peptide, and ACPRmax were not related to glucagon. Fasting glucose and glucagon were positively correlated in adults (r = 0.133, P = 0.012) and negatively correlated in youth (r = -0.143, P = 0.251). In both age-groups, higher fasting glucagon was associated with higher fasting C-peptide (youth r = 0.209, P = 0.091; adults r = 0.335, P < 0.001) and lower insulin sensitivity (youth r = -0.228, P = 0.066; adults r = -0.324, P < 0.001). With comparable fasting glucagon, youth had greater C-peptide and lower insulin sensitivity. OGTT suppression of glucagon was greater in youth. Conclusions: Youth with IGT or recently diagnosed type 2 diabetes (drug naive) have hyperresponsive β-cells and lower insulin sensitivity, but their glucagon concentrations are not increased compared with those in adults. Thus, α-cell dysfunction does not appear to explain the difference in β-cell function and insulin sensitivity in youth versus adults.
dc.eprint.versionFinal published version
dc.identifier.citationKahn SE, Mather KJ, Arslanian SA, et al. Hyperglucagonemia Does Not Explain the β-Cell Hyperresponsiveness and Insulin Resistance in Dysglycemic Youth Compared With Adults: Lessons From the RISE Study. Diabetes Care. 2021;44(9):1961-1969. doi:10.2337/dc21-0460
dc.identifier.urihttps://hdl.handle.net/1805/35301
dc.language.isoen_US
dc.publisherAmerican Diabetes Association
dc.relation.isversionof10.2337/dc21-0460
dc.relation.journalDiabetes Care
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectBlood glucose
dc.subjectType 2 diabetes mellitus
dc.subjectInsulin
dc.subjectInsulin resistance
dc.subjectInsulin secretion
dc.titleHyperglucagonemia Does Not Explain the β-Cell Hyperresponsiveness and Insulin Resistance in Dysglycemic Youth Compared With Adults: Lessons From the RISE Study
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
dc210460.pdf
Size:
1.29 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: